P-Glycoprotein Expression by Peripheral Blood Mononuclear Cells from Human Immunodeficiency Virus-Infected Patients Is Independent from Response to Highly Active Antiretroviral Therapy

This publication has 18 references indexed in Scilit:

• Short Communication:Expression of P-Glycoprotein and Multidrug Resistance-Associated Protein in Healthy Volunteers and HIV-Infected Patients
  AIDS Research and Human Retroviruses, 2001
• The Role of Genotypic Resistance Testing in Selecting Therapy for HIV
  JAMA, 2000
• May the Drug Transporter P Glycoprotein Affect the Antiviral Activity of Human Immunodeficiency Virus Type 1 Proteinase Inhibitors?
  Antimicrobial Agents and Chemotherapy, 2000
• The drug transporter P-glycoprotein limits oral absorption and brain entry of HIV-1 protease inhibitors.
  Journal of Clinical Investigation, 1998
• Abnormal Expression of a 170-Kilodalton P-Glycoprotein Encoded byMDR1Gene, a Metabolically Active Efflux Pump, in CD4⁺and CD8⁺T Cells from Patients with Human Immunodeficiency Virus Type 1 Infection
  AIDS Research and Human Retroviruses, 1996
• P-glycoprotein in the blood-brain barrier of mice influences the brain penetration and pharmacological activity of many drugs.
  Journal of Clinical Investigation, 1996
• Transmembrane P-Glycoprotein (P-gp/P-170) in HIV Infection: Analysis of Lymphocyte Surface Expression and Drug-Unrelated Function
  AIDS Research and Human Retroviruses, 1995
• Preferential expression and activity of multidrug resistance gene 1 product (P-glycoprotein), a functionally active efflux pump, in human CD8 + T cells: A role in cytotoxic effector function
  Journal of Clinical Immunology, 1992
• Resistance of HIV-1 to AZT Might Also Involve the Cellular Expression of Multidrug Resistance P-Glycoprotein
  AIDS Research and Human Retroviruses, 1992
• Multidrug resistance activity in human lymphocytes
  Human Immunology, 1991